Back

Assessment of multiplex digital droplet RT-PCR as an accurate diagnosis tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples

CASSINARI, K.; Alessandri, E.; Chambon, P.; Charbonnier, F.; Gracias, S.; Beaussire, L.; Alexandre, K.; Sarafan-Vasseur, N.; Houdayer, C.; Etienne, M.; Caron, F.; Plantier, J.-C.; Frebourg, T.

2020-08-04 infectious diseases
10.1101/2020.08.02.20166694
Show abstract

RT-qPCR on nasopharyngeal swabs is currently the reference COVID-19 diagnosis method. We developed a multiplex RT-ddPCR assay, targeting six SARS-CoV-2 genomic regions, and evaluated it on nasopharyngeal swabs and saliva samples collected from 130 COVID-19 positive or negative ambulatory individuals, who presented symptoms suggestive of mild or moderate Sars-CoV2 infection. The 6-plex RT-ddPCR assay was shown to have 100% sensitivity on nasopharyngeal swabs and a higher sensibility than RT-qPCR on saliva (85% versus 62%). Saliva samples from 2 individuals with negative results on nasopharyngeal swabs were found to be positive. These results show that multiplex RT-ddPCR should represent an alternative and complementary tool for the diagnosis of COVID-19, in particular to control RT-qPCR ambiguous results, and its application to saliva an appropriate strategy for repetitive sampling and testing individuals for whom nasopharyngeal swabbing is not possible.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS ONE
based on 1737 papers
Top 41%
12.5%
2
Scientific Reports
based on 701 papers
Top 24%
7.6%
3
Journal of Clinical Microbiology
based on 77 papers
Top 1%
7.6%
4
Journal of Medical Virology
based on 95 papers
Top 1%
5.8%
5
Journal of Clinical Virology
based on 54 papers
Top 0.4%
5.3%
6
European Journal of Clinical Microbiology & Infectious Diseases
based on 14 papers
Top 0.1%
4.7%
7
International Journal of Infectious Diseases
based on 115 papers
Top 2%
4.5%
8
Journal of Virological Methods
based on 20 papers
Top 0.5%
4.5%
50% of probability mass above
9
Clinical Chemistry
based on 14 papers
Top 0.1%
3.0%
10
Emerging Infectious Diseases
based on 84 papers
Top 4%
2.5%
11
Diagnostics
based on 36 papers
Top 2%
2.3%
12
Journal of Infection
based on 64 papers
Top 2%
2.3%
13
Frontiers in Cellular and Infection Microbiology
based on 22 papers
Top 1%
2.3%
14
Clinical Microbiology and Infection
based on 54 papers
Top 2%
2.3%
15
Microbiology Spectrum
based on 86 papers
Top 1%
2.3%
16
Nature Communications
based on 483 papers
Top 31%
1.6%
17
Viruses
based on 79 papers
Top 3%
1.6%
18
Open Forum Infectious Diseases
based on 124 papers
Top 7%
1.3%
19
Frontiers in Medicine
based on 99 papers
Top 14%
1.3%
20
Clinical Infectious Diseases
based on 219 papers
Top 16%
1.3%
21
The Journal of Molecular Diagnostics
based on 24 papers
Top 2%
1.2%
22
Diagnostic Microbiology and Infectious Disease
based on 15 papers
Top 0.7%
0.8%
23
The Journal of Infectious Diseases
based on 137 papers
Top 10%
0.8%
24
Journal of Infection and Chemotherapy
based on 15 papers
Top 0.7%
0.8%
25
Clinical Chemistry and Laboratory Medicine (CCLM)
based on 11 papers
Top 0.7%
0.8%
26
Journal of Medical Microbiology
based on 14 papers
Top 1%
0.8%
27
Analytical Chemistry
based on 15 papers
Top 1%
0.7%
28
Frontiers in Microbiology
based on 36 papers
Top 4%
0.7%
29
Science Translational Medicine
based on 40 papers
Top 5%
0.7%